Advanced salivary gland carcinoma expressing androgen receptor and HER2: targeted therapies first?

Ann Oncol. 2020 Jul;31(7):958-959. doi: 10.1016/j.annonc.2020.03.302. Epub 2020 Apr 7.

Authors

E Quaquarini¹, F Sottotetti², D Presti²

Affiliations

¹ Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy. Electronic address: erica.quaquarini@icsmaugeri.it.
² Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy.

PMID: 32275947
DOI: 10.1016/j.annonc.2020.03.302

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Receptor, ErbB-2 / genetics
Receptors, Androgen* / genetics
Salivary Gland Neoplasms* / drug therapy
Salivary Glands

Substances

Receptors, Androgen
Receptor, ErbB-2